Log on / register
Feedback | Support | My details

Email this article to a friend

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells

M Goffinet email, M Thoulouzan email, A Pradines email, I Lajoie-Mazenc email, Carolyn Weinbaum email, JC Faye email and S Séronie-Vivien email

BMC Cancer 2006, 6:60doi:10.1186/1471-2407-6-60

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.